Wait-and-See Treatment Strategy Could be Considered for Lung Adenocarcinoma with Special Pleural Dissemination Lesions, and Low Genomic Instability Correlates with Better Survival
- 1 April 2020
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 27 (10) , 3808-3818
Abstract
This study aimed to evaluate the feasibility of a wait-and-see strategy for non-small cell lung cancer (NSCLC) patients with special pleural disseminationKeywords
Funding Information
- Health Collaborative Innovation Major Project from Guangzhou Science and Technology Bureau (201400000001-2)
- Project of National Natural Science Foundation (81673031, 81872510)
- Key Lab System Project of Guangdong Science and Technology Department–Guangdong Provincial Key Lab of Translational Medicine in Lung Cancer (2012A061400006/2017B030314120)
- Guangdong Provincial People's Hospital Young Talent Project (GDPPHYTP201902)
- High-level Hospital Construction Project (DFJH201801)
This publication has 24 references indexed in Scilit:
- Watch and Wait Approach for Re-excision After Unplanned Yet Macroscopically Complete Excision of Extremity and Superficial Truncal Soft Tissue Sarcoma is Safe and Does Not Affect Metastatic Risk or Amputation RateAnnals of Surgical Oncology, 2019
- Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-UpJournal of Clinical Oncology, 2018
- Lung adenocarcinoma with intraoperatively diagnosed pleural seeding: Is main tumor resection beneficial for prognosis?The Journal of Thoracic and Cardiovascular Surgery, 2018
- Role of chromosomal instability in cancer progressionEndocrine-Related Cancer, 2017
- Tracking the Evolution of Non–Small-Cell Lung CancerNew England Journal of Medicine, 2017
- Should primary tumor be resected for non-small cell lung cancer with malignant pleural disease unexpectedly found during operation?—a systemic review and meta-analysisJournal of Thoracic Disease, 2016
- The IASLC Lung Cancer Staging ProjectJournal of Thoracic Oncology, 2015
- Evolutionary Determinants of CancerCancer Discovery, 2015
- Survival of M1a Non-Small Cell Lung Cancer Treated Surgically: A Retrospective Single-Center StudyThe Thoracic and Cardiovascular Surgeon, 2015
- Guidelines on Treatment of Stage IIIB Non-small Cell Lung Cancer*Chest, 2003